Biotech Showcase
Join us virtually
January 10–12, 2022 &January 17–19, 2022

Francesco Lavino
CEO at F2G


Francesco has over 20 years of pharma and biotech experience in strategic and operational roles in US, Europe and Emerging Markets. He served as Chief Commercial Officer at Nabriva Therapeutics from July 2017, where he led the commercial organization buildout and the launch of Xenleta, a first-in-class new antibiotic treatment. Prior to Nabriva, he spent almost 15 years at Merck and Cubist Pharmaceuticals in different commercial roles and therapeutic areas at global, regional and country level. He held the position of Global Brand Leader for the Anti-Infective Portfolio (2015-2017) and before has been the commercial lead of the Merck Antifungal Portfolio in EMEAC (2009-2010) and Globally (2011-2013). Francesco began his career in pharmaceutical sales in Italy and holds a BS in Pharmacy from Federico II University of Naples, Italy and a MBA from SDA Bocconi School of Management in Milan, Italy.

Agenda Sessions

  • The Decision to Launch on your Own: Critical Success Factors